Event

Connect with Quotient Sciences at the upcoming 14th Drug Delivery and Formulation Summit in Berlin from 31st May to 2nd June.

Schedule a meeting

News

Quotient Sciences Announces Significant Growth in Workforce at Alnwick, UK, Facility

Quotient Sciences has grown the workforce at its Alnwick, UK, facility by 20% over the past 2 years.

Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility

A £6 million project expands Quotient Sciences' Alnwick, UK into a state-of-the-art drug substance manufacturing facility that can deliver integrated support for customers from candidate selection through to early clinical development and beyond.

Quotient Sciences Completes Qualification of GastroPlus® PBPK Modeling Software

Quotient Sciences’ Modeling and Simulation (M&S) team has recently completed qualification of GastroPlus software for physiologically based pharmacokinetic (PBPK) modeling.

Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs

Quotient Sciences has completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs.

Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic

State-of-the-Art Compounding Pharmacy Will Accelerate Early Development Programs

Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.

Quotient Sciences announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, PA. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing.